Innoviva, Inc., 10% Owner, Director at Entasis Therapeutics Holdings Inc. (ETTX), bought 3,731,025 shares at $2.00 ($7.5M) on 2021-05-03, disclosed to the SEC on 2021-05-20.
Open-market purchase of $7.5M ETTX by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ETTX | BUY | 2020-09-01 | $25.0M | — | Filing → |
| ETTX | BUY | 2020-06-12 | $31.7M | — | Filing → |
| ARMP | BUY | 2020-03-31 | $44.3M | — | Filing → |